[This corrects the article DOI: 10.3389/fimmu.2024.1496992.].
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11656050 | PMC |
| http://dx.doi.org/10.3389/fimmu.2024.1536312 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Corrigendum: Research progress of CD80 in the development of immunotherapy drugs.
Front Immunol
December 2024
Department of Respiratory Medicine, The Second Affiliated Hospital of Chongqing Medical University, Chongqing, China.
[This corrects the article DOI: 10.3389/fimmu.2024.
View Article and Find Full Text PDFCorrigendum to "Luteolin and its analog luteolin-7-methylether from Leonurus japonicus Houtt. Suppress aromatase-mediated estrogen biosynthesis to alleviate polycystic ovary syndrome by the inhibition of tumor progression locus 2" [J. Ethnopharmacol. (331), (2024) 118279].
J Ethnopharmacol
December 2024
Center for Natural Products Research, Chengdu Institute of Biology, Chinese Academy of Sciences, Chengdu 610041, China. Electronic address:
Corrigendum to "ACAT1 suppresses clear cell renal cell carcinoma progression by AMPK mediated fatty acid metabolism" [Transl Oncol 47:102043(Sep 2024) 102043].
Transl Oncol
January 2025
Department of Urology, Jingzhou Central hospital affiliated to Yangtze University, 26 Chuyuan Avenue, Jing zhou District, Jingzhou City, 434000. Electronic address:
Corrigendum to "TRIP4 transcriptionally activates DDIT4 and subsequent mTOR signaling to promote glioma progression" [Free Radic. Biol. Med. 177 (2021) 31-47].
Free Radic Biol Med
December 2024
Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center of Cancer Medicine, Guangzhou, China. Electronic address:
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!